Clinical Trial Update: Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena? [Phase 4]

View source ↗

Summary

Phase 4 trial exploring whether vitamin D2 treatment-related decreases in 25(OH)D3 represent a reciprocal phenomenon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitamin Deficiency

Drugs mentioned

• Vitamin D2 (ergocalciferol)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Vitamin D Deficiency, 25-Hydroxyvitamin D Concentration | Phase 4 | Status: COMPLETED